Diane Holder Buys 2,735 Shares of Evolent Health, Inc. (NYSE:EVH) Stock

Evolent Health, Inc. (NYSE:EVH - Get Free Report) Director Diane Holder acquired 2,735 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were bought at an average cost of $9.33 per share, with a total value of $25,517.55. Following the purchase, the director now owns 70,584 shares of the company's stock, valued at approximately $658,548.72. This trade represents a 4.03 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Evolent Health Stock Up 0.3 %

EVH traded up $0.03 during midday trading on Thursday, reaching $9.51. The company's stock had a trading volume of 2,112,922 shares, compared to its average volume of 2,076,186. Evolent Health, Inc. has a 1 year low of $8.35 and a 1 year high of $34.07. The stock's 50-day moving average is $10.26 and its 200-day moving average is $17.23. The firm has a market capitalization of $1.11 billion, a price-to-earnings ratio of -11.59 and a beta of 1.49. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.58.

Evolent Health (NYSE:EVH - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The technology company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.38 by ($0.35). Evolent Health had a negative net margin of 2.41% and a positive return on equity of 5.73%. The company had revenue of $646.54 million for the quarter, compared to the consensus estimate of $650.92 million. As a group, research analysts expect that Evolent Health, Inc. will post 0.08 EPS for the current year.

Remove Ads

Hedge Funds Weigh In On Evolent Health

A number of hedge funds have recently bought and sold shares of the company. Pilgrim Partners Asia Pte Ltd bought a new stake in Evolent Health during the 4th quarter valued at about $26,000. R Squared Ltd purchased a new stake in shares of Evolent Health during the fourth quarter valued at approximately $31,000. AlphaQuest LLC increased its position in shares of Evolent Health by 21,650.0% during the fourth quarter. AlphaQuest LLC now owns 3,045 shares of the technology company's stock valued at $34,000 after acquiring an additional 3,031 shares in the last quarter. Covestor Ltd raised its holdings in Evolent Health by 138.1% in the 3rd quarter. Covestor Ltd now owns 1,424 shares of the technology company's stock worth $40,000 after acquiring an additional 826 shares during the last quarter. Finally, Parkside Financial Bank & Trust lifted its position in Evolent Health by 90.7% in the 4th quarter. Parkside Financial Bank & Trust now owns 4,957 shares of the technology company's stock valued at $56,000 after acquiring an additional 2,358 shares in the last quarter.

Wall Street Analyst Weigh In

EVH has been the subject of several recent analyst reports. Citigroup lowered their price objective on shares of Evolent Health from $21.00 to $18.00 and set a "buy" rating for the company in a research note on Friday, January 10th. Truist Financial lowered their price target on Evolent Health from $20.00 to $15.00 and set a "buy" rating for the company in a research report on Wednesday, January 22nd. JMP Securities reissued a "market outperform" rating and set a $12.00 target price on shares of Evolent Health in a research note on Friday, February 14th. Stephens decreased their target price on Evolent Health from $16.00 to $12.00 and set an "equal weight" rating for the company in a report on Tuesday, January 21st. Finally, JPMorgan Chase & Co. cut their price target on shares of Evolent Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Monday. One investment analyst has rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $17.71.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.